HNB
SGMO

Huntington National Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Huntington National Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,038
Closed -$372 – 4207
2024
Q2 		$372 Buy
1,038
+43
+4% +$23 ﹤0.01% 2472
2024
Q1 		$667 Buy
995
+173
+21% +$125 ﹤0.01% 2328
2023
Q4 		$447 Buy
+822
New +$379 ﹤0.01% 2300
2018
Q4 		– Sell
-2,000
Closed -$34K – 1845
2018
Q3 		$34K Buy
+2,000
New +$30.4K ﹤0.01% 1094

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Huntington National Bank's SGMO Position: Q3 2024 in Review

Huntington National Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 1,038 shares — an estimated $372 sold.

Huntington National Bank first reported a position in SGMO in Q3 2018 and held it in 4 quarters. The position peaked at $34K in Q3 2018. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • Huntington National Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • Huntington National Bank sold 1,038 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $372.
  • Huntington National Bank first reported a position in SANGAMO THERAPEUTICS INC in Q3 2018 and held it in 4 quarters.
  • Huntington National Bank's SANGAMO THERAPEUTICS INC position peaked at $34K in Q3 2018.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on Huntington National Bank's 13F filing for Q3 2024, filed 6 Nov 2024.